A research team headed by Professor Tsvee Lapidot of Israel’s Weizmann Institute’s immunology Department has discovered that the body’s precious stem cells – special bodies which can morph into many different types in order to provide vital services to the body in cases of need – have a little help in the immune system.
According to the paper, reported on by Israel21c, stem cells have backup from a sub-group of activated immune cells whose sole purpose is to defend them.
While the presence of mesenchymal cells – cells which provide support to stem cells in order to keep them healthy and strong – was already known, Dr. Lapidot’s team discovered that a subgroup of cells exists which prevent the differentiation of stem cells, secreting prostaglandins which preserve the youthfulness of the stem cells and prevent them from turning into anything else – also helping them survive chemotherapy or respond to infections.
Lapidot’s study further showed that introducing prostaglandin treatments can improve the quality and increase the number of the stem cells, an important discovery which may impact the strength and amount of cures to patients with leukemia.
About the Author: Malkah Fleisher is a graduate of Cardozo Law School in New York City. She is an editor/staff writer at JewishPress.com and co-hosts a weekly Israeli FM radio show. Malkah lives with her husband and two children on the Mount of Olives in Jerusalem.
If you don't see your comment after publishing it, refresh the page.
Our comments section is intended for meaningful responses and debates in a civilized manner. We ask that you respect the fact that we are a religious Jewish website and avoid inappropriate language at all cost.
If you promote any foreign religions, gods or messiahs, lies about Israel, anti-Semitism, or advocate violence (except against terrorists), your permission to comment may be revoked.